Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, July 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 3 public wall posts from 3 users.

Cjepivo palivizumaba za sprječavanje infekcije respiratornim sincicijskim virusom u djece oboljele od cistične…

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis https://t.co/YJoXO9q9p…

http://www.cochrane.org/ru/CD007743/vakcina-palivizumaba-dlya-predotvrashcheniya-respiratorno-sincitialnoy-virusnoy-infekcii-u-de…